Nextech Invest

Investor type

VC

Founded

1998

AUM

$100 M

Location

Zurich, Zurich, Switzerland

Investment Ticket

$10-50 m

Investment Stage

Seed Series A Series B Late Stage (Series C+)

Region of investment

Europe North America

ESG Focus

Impact investor
Investor profile last updated: 21 August, 2026

Profile

Nextech Invest is a venture capital firm specializing in the life sciences sector, particularly in biotechnology and pharmaceuticals. The firm is based in Switzerland and the USA, drawing on a deep reservoir of global scientific and investment expertise to support innovative companies aimed at advancing healthcare solutions. The team is composed of experienced partners and scientific advisors known for their strategic insights and profound knowledge of the biotechnology domain. What sets Nextech apart is its fusion of scientific expertise and rigorous investment methods to significantly contribute to patient care and provide strong returns for their investors.

The firm focuses on sectors such as biotechnology, pharmaceuticals, and healthtech, investing predominantly in early to late-stage companies. While specific check sizes are not detailed on the site, their fund sizes and healthcare focus suggest significant participation in series A to late-stage rounds. Nextech Invest collaborates with strategic partners to facilitate robust growth and successful business strategies for its portfolio companies.

Notable investments include companies like Foundation Medicine, acquired by Roche for $5 billion, Blueprint Medicines, Relay Therapeutics, and Tango Therapeutics among others. These investments demonstrate Nextech's commitment to supporting groundbreaking health science innovations that have a lasting impact on patient care and the healthcare industry worldwide.

Industry

Biotechnology Healthcare Services HealthTech Pharmaceuticals MedTech Life Sciences

Nextech Invest Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Nextech Fund II
Venture Capital (VC)
Biotechnology
Healthcare Services
Life Sciences
Pre-seed
Seed
North America
Europe
$5-10 m
$100 M
October 2014

Contacts

Name
Title
Email
avatar
Rocco Sgobbo Partner
Partner
r•••@•••
avatar
Niresh Berinpanathan Principal
Principal
n•••@•••
Upgrade to see contacts
avatar
ZKd5F1axeLmv8VEp ZKd5F1axeLmv8VEp
ZKd5F1axeLmv8VEp
avatar
ZKd5F1axeLmv8VEp ZKd5F1axeLmv8VEp
ZKd5F1axeLmv8VEp
avatar
ZKd5F1axeLmv8VEp ZKd5F1axeLmv8VEp
ZKd5F1axeLmv8VEp
Investment-team contacts for Nextech Invest — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Nextech Invest

Nextech Invest is a venture capital firm. It backs companies at Seed, Series A, Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Nextech Invest is located in Zurich, Zurich, Switzerland.
Nextech Invest was founded in 1998.
Nextech Invest invests in companies and startups in Biotechnology, Healthcare Services, HealthTech, Pharmaceuticals, MedTech, Life Sciences.
Nextech Invest invests in companies and startups in Europe, North America.
Nextech Invest invests in companies and startups at Seed, Series A, Series B, Late Stage (Series C+).
Nextech Invest usually invests $10-50 m on average.
Nextech Invest has around $100m assets under management.
Nextech Invest last fund was created/launched in 2014-10-14
Yes, Nextech Invest is impact investor.
Nextech Invest can be reached through its website nextechinvest.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Nextech Invest — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Nextech Invest directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.